Monopar Therapeutics Inc.
MNPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $45,816 | $7,266 | $8,186 | $20,304 |
| Short-Term Investments | $14,396 | $0 | $4,934 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $79 | $66 | $46 | $218 |
| Total Curr. Assets | $60,291 | $7,333 | $13,166 | $20,522 |
| Property Plant & Equip (Net) | $0 | $13 | $61 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $13 | $61 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $60,291 | $7,345 | $13,227 | $20,522 |
| Liabilities | – | – | – | – |
| Payables | $2,254 | $1,757 | $3,129 | $1,581 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,000 | $0 | $0 | $0 |
| Total Curr. Liab. | $5,254 | $1,757 | $3,129 | $1,581 |
| LT Debt | $0 | $0 | $8 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $8 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $8 | $0 |
| Total Liabilities | $5,254 | $1,757 | $3,137 | $1,581 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $15 | $13 | $13 |
| Retained Earnings | -$75,793 | -$60,206 | -$51,804 | -$41,288 |
| AOCI | $36 | -$14 | $9 | -$3 |
| Other Equity | $130,787 | $65,793 | $61,872 | $60,220 |
| Total Equity | $55,037 | $5,588 | $10,090 | $18,941 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $60,291 | $7,345 | $13,227 | $20,522 |
| Net Debt | -$45,816 | -$7,266 | -$8,178 | -$20,304 |